PAR paradigm biopharmaceuticals limited..

Yes again great research and story telling here that aligns with...

  1. 10,383 Posts.
    lightbulb Created with Sketch. 1414
    Yes again great research and story telling here that aligns with our aspirations for investing in PAR.

    It wouldn't be a waste of time I believe if we start discussing the "blind spots" that are present with our thesis given this is PR and the PAR teams first live run together at achieving certification. Moreover, how relevant DMOAD is to our near ten future success is still a big question mark as PAR have yet to articulate how it will be influenced by the various P3 streams.

    If we get some consensus of what shareholders collectively have assessed as possible "blind spots" (unknown risks) it could then be feedback to PR to focus his future presentations.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
45.0¢
Change
-0.015(3.23%)
Mkt cap ! $184.8M
Open High Low Value Volume
47.0¢ 47.5¢ 43.0¢ $162.8K 357.4K

Buyers (Bids)

No. Vol. Price($)
6 68560 45.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 5665 1
View Market Depth
Last trade - 10.19am 07/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.